Trial: 202008003

Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

Phase

II

Principal Investigator

Bartlett, Nancy

Disease Site

Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov